Lower Serum Caveolin-1 Is Associated with Cerebral Microbleeds in Patients with Acute Ischemic Stroke

Table 2

Logistic regression analysis for association between Cav-1 and cSVD.

Cav-1

CMBs

SLIs

WMHs

Model 1

Model 2

Model 1

Model 2

Model 1

Model 2

≤5.25 ng/mL

3.69 (1.78–7.64)

0.00044

4.05 (1.77–9.30)

0.001

1.30 (0.68–2.50)

0.431

1.61 (0.77–3.36)

0.209

0.88 (0.45–1.70)

0.696

0.77 (0.36–1.67)

0.510

>5.25 ng/mL

Reference

Reference

Reference

Reference

Reference

Reference

Model 1, adjusted for age and sex; Model 2, adjusted for age, sex, hypertension, diabetes mellitus, dyslipidemia, heart disease, BMI, smoking, alcohol intake, SBP, DBP, antithrombotics use, onset-to-MRI time, onset-to-blood drawing time, NIHSS, fasting glucose, triglycerides, HDL, LDL, total cholesterol, and fibrinogen.
CMBs, cerebral microbleeds; SLIs, silent lacunar infarcts; WMHs, white matter hyperintensities.